Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 4

V1. Studies of the epidemiology of viral infections

Session: Clinical Quandries in Viral Infections in ICH

21 - Efficacy and Safety of Maribavir as a Rescue Treatment for Investigator Assigned Therapy in Transplant Recipients With Refractory or Resistant Cytomegalovirus Infections in the SOLSTICE Study: Phase 3 Trial Results

On Demand
Participants should be aware of the following financial/non-financial relationships:
Marcus R. Pereira, MD MPH: Hologic (Scientific Research Study Investigator)Merck (Scientific Research Study Investigator)Takeda (Scientific Research Study Investigator, Advisor or Review Panel member)
Carlos Cervera, MD, PhD: Avir Pharma (Consultant, Advisor or Review Panel member)Lilly (Consultant, Advisor or Review Panel member)Merck (Consultant, Advisor or Review Panel member, Research Grant or Support)Sunovion (Consultant, Advisor or Review Panel member)Takeda (Consultant, Advisor or Review Panel member)Veritas Pharma (Consultant, Advisor or Review Panel member)
Camille Kotton, MD: UpToDate (Individual(s) Involved: Self): I write chapters on zoonoses for UpToDate., Independent Contractor
Joseph Sasadeusz, MBBS, PhD: Abbvie (Grant/Research Support, Other Financial or Material Support, Consulting fee: speaker)Gilead (Other Financial or Material Support, Speaker)Merck (Grant/Research Support, Consulting fee: speaker)Takeda (Grant/Research Support)
Jingyang Wu, MS: Shire Human Genetic Therapies, Inc., a Takeda company (Employee, Other Financial or Material Support, Holds stock/stock options)
Martha Fournier, MD: Shire Human Genetic Therapies, Inc., a Takeda company (Employee, Other Financial or Material Support, Holds stock/stock options)Shire ViroPharma, a Takeda company (Other Financial or Material Support, This study was funded by Shire ViroPharma, a Takeda company)

    Presenting Author(s)

  • Marcus R. Pereira, MD MPH

    Assistant Professor of Medicine
    Columbia University College of Physicians and Surgeons
    New York, NY, United States

    Hologic (Scientific Research Study Investigator)Merck (Scientific Research Study Investigator)Takeda (Scientific Research Study Investigator, Advisor or Review Panel member)

    Slides Slides and Audio

    • Co-Author(s)

  • CC

    Carlos Cervera, MD, PhD

    Assistant Professor
    University of Alberta
    Edmonton, AB, Canada

    Avir Pharma (Consultant, Advisor or Review Panel member)Lilly (Consultant, Advisor or Review Panel member)Merck (Consultant, Advisor or Review Panel member, Research Grant or Support)Sunovion (Consultant, Advisor or Review Panel member)Takeda (Consultant, Advisor or Review Panel member)Veritas Pharma (Consultant, Advisor or Review Panel member)

  • Camille Kotton, MD

    clinical director, transplant ID
    Massachusetts General Hospital
    Boston, MA, United States

    Shire/Takeda (Advisor or Review Panel member)

  • JS

    Joseph Sasadeusz, MBBS, PhD

    Royal Melbourne Hospital
    Melbourne, Victoria, Australia

    Abbvie (Grant/Research Support, Other Financial or Material Support, Consulting fee: speaker)Gilead (Other Financial or Material Support, Speaker)Merck (Grant/Research Support, Consulting fee: speaker)Takeda (Grant/Research Support)

  • JW

    Jingyang Wu, MS

    Shire Human Genetic Therapies, Inc., a Takeda company
    Lexington, Massachusetts, United States

    Shire Human Genetic Therapies, Inc., a Takeda company (Employee, Other Financial or Material Support, Holds stock/stock options)

  • MF

    Martha Fournier, MD

    Shire Human Genetic Therapies, Inc., a Takeda company
    Lexington, Massachusetts, United States

    Shire Human Genetic Therapies, Inc., a Takeda company (Employee, Other Financial or Material Support, Holds stock/stock options)Shire ViroPharma, a Takeda company (Other Financial or Material Support, This study was funded by Shire ViroPharma, a Takeda company)